Holen Sie sich die Stockscreener-App
11.27
5.61%
-0.67
Handel nachbörslich:
11.27
Medifast Inc Aktie (MED) Neueste Nachrichten
New coaching twist, Medifast’s OPTAVIA app deepens its weight-loss ecosystem - AD HOC NEWS
Medifast Inc Stock (US58470S1024): valuation in focus after steep multi-year slide - AD HOC NEWS
Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight Management - GlobeNewswire
Medifast (MED) down 5.1% since last earnings report: Can it rebound? - MSN
MED News | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
Medifast chief legal officer Jason Groves resigns; company begins search for successor - Investing.com UK
Medifast chief legal officer Jason Groves resigns; company begins search for successor By Investing.com - Investing.com South Africa
Medifast (MED) Files 8-K Announcing Executive Separation Agreement with Jason Groves - Minichart
Medifast's Jason L. Groves resigns as Chief Legal Officer & Corporate Secretary - TradingView
[8-K] MEDIFAST INC Reports Material Event - Stock Titan
MED News Today | Why did Medifast stock drop today? $MED - MarketBeat
Medifast (MED) director takes equity awards instead of cash for board service - Stock Titan
Medifast (NYSE: MED) director Kiai Parsa takes equity grants in lieu of cash fees - Stock Titan
Medifast (MED) director receives 11,680 RSUs as annual fee compensation - Stock Titan
Medifast (NYSE: MED) director receives 11,680 restricted stock units award - Stock Titan
Medifast (NYSE: MED) director awarded 11,680 restricted stock units in fee grant - Stock Titan
Cash-settled RSU grant boosts Medifast (MED) director derivative holdings - Stock Titan
Medifast Inc (NYSE: MED) director Jeffrey Rose files routine Form 3 - Stock Titan
Medifast (NYSE: MED) director details 657,590 indirect shares - Stock Titan
What is Zacks Research's Forecast for Medifast Q2 Earnings? - MarketBeat
Medifast Appoints Nicholas Johnson as New CEO and Amends 2012 Share Incentive Plan - Minichart
Medifast Names Nicholas Johnson as CEO - Moomoo
Medifast Taps Johnson to Succeed Chard as CEO - Moomoo
Medifast names Nicholas Johnson as CEO effective June 1 By Investing.com - Investing.com South Africa
Nicholas Johnson becomes Medifast (NYSE: MED) CEO as investors back equity plan - Stock Titan
Medifast, Inc. Approves Board Elections - marketscreener.com
Medifast names Nicholas Johnson as CEO effective June 1 - Investing.com
Medifast confirms appointment of Nicholas Johnson as chief executive officer - marketscreener.com
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer - Business Wire
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026 - MSN
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - Sahm
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - GlobeNewswire Inc.
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes - Sahm
MEDIFAST INC (MED) Surges +1.12%, Nearing $13.22 Resistance 2026-05-19Call Spread Alert - thelegaladvocate.com
Citadel reports 6.5% stake in MEDIFAST (MED) in joint Schedule 13G - Stock Titan
MED | Medifast, Inc. FinancialsIncome Statement - Quiver Quantitative
Charles Schwab (MED) reports 631,539 shares, 5.74% stake (03/31/2026) - Stock Titan
Renaissance Holdings amends Schedule 13G: 773,710 shares in MED (MED) - Stock Titan
Why Medifast's $15 Cash Per Share Makes It A Strong Buy (NYSE:MED) - Seeking Alpha
Medifast director Scott Schlackman buys $62,950 in company stock By Investing.com - Investing.com Nigeria
Medifast director Scott Schlackman buys $62,950 in company stock - Investing.com
Medifast (MED) director Scott Schlackman adds 5,000 shares in open-market buys - Stock Titan
TradingKey - TradingKey
Medifast: Worth Putting On A Watchlist (NYSE:MED) - Seeking Alpha
MED Technical Analysis | Trend, Signals & Chart Patterns | MEDIFAST INC (NYSE:MED) - ChartMill
Why is Medifast stock surging despite weak Q1? $30M cost-cut plan - MSN
Document - SEC.gov
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - The Globe and Mail
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):